Dexamethasone for critically ill COVID-19 patients - Clinical Practice Guidelines (CPG) on EBMonFHIR v1.0.2

Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - ci-build

Clinical Practice Guidelines (CPG) on EBMonFHIR, published by Universitätsmedizin Greifswald. This guide is not an authorized publication; it is the continuous build for version 1.0.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CEOsys/cpg-on-ebm-on-fhir/ and changes regularly. See the Directory of published versions

Example ArtifactAssessment: Dexamethasone for critically ill COVID-19 patients

Generated Narrative: ArtifactAssessment DexamethasoneRecommendationJustification

ArtifactAssessment Version: v4.0

ArtifactAssessment Publication Status: active

date: 2020-01-03

artifact: PlanDefinition Dexamethasone Application in ventilated COVID-19 patients

content
informationType: Rating
type: Strength of recommendation
classifier: Strong for an intervention

content
informationType: Rating
type: Consensus
classifier: Strong

content
informationType: Rating
type: Preference and values
classifier: Factor not considered

content
informationType: Rating
type: Resources
classifier: No important issues

content
informationType: Rating
type: Acceptability
classifier: Factor not considered

content
informationType: Rating
type: Feasibility
classifier: Factor not considered

content
informationType: Container
type: Certainty of evidence rating
RelatedArtifacts
- Type Classifier ResourceReference
* Justification Certainty of evidence rating ArtifactAssessment: extension = v4.0,active; date = 2020-01-03; artifact[x] = ->Evidence ExampleOutcomeEvidence